Qiagen launches automated sample processing for molecular testing

By LabPulse.com staff writers

March 4, 2021 -- Qiagen has announced the launch of a fully automated sample processing platform for IVD applications in molecular diagnostic laboratories.

The QIAcube Connect MDx platform is compatible with the company's QIAamp digital signal processing kits and PAXgene blood RNA extraction kits. A remote monitoring feature allows lab personnel to connect to the company's QIAsphere digital platform and track progress through the workflow using an app, according to the company.

The new platform is available in the U.S., Canada, the European Union, and other global markets.

Qiagen, Inovio to partner on cervical dysplasia test
Qiagen and Inovio have announced they will develop a next-generation sequencing test for HPV-linked advanced cervical dysplasia that can be used on Illumina's...
Qiagen debuts solution for SARS-CoV-2 T-cell research
Qiagen has launched the QuantiFeron SARS-CoV-2 Research Use Only solution to detect T-cell responses to the novel coronavirus. The solution could aid...
Qiagen to launch rapid portable SARS-CoV-2 antigen test
Qiagen plans to launch the Access Anti-SARS-CoV-2 antigen test, a rapid portable test that can detect novel coronavirus antigens in people with active...

Copyright © 2021 LabPulse.com

Last Updated ls 3/4/2021 6:13:54 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current